NF1 and neuroblastoma: Thus, the overexpression of MYCN blocks the differentiation of sympathoadrenal precursor cells, leaving them vulnerable to the potentiating effects of nf1 loss on RAS pathway activation, which in turn leads to the marked increased in neuroblastoma penetrance and growth rate.